ARCHIVES

Phase III Regorafenib Trial Meets PFS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

New Predictive Score May Help In Planning Adjuvant Therapy

September 26, 2008

DCE Board Approves Concepts For Three New RFA Programs

July 6, 1984

Clinton’s FY97 Budget Sees $12.4 Billion For NIH, $2.28B For NCI

March 22, 1996

New Task Force For Nutrition Research Urged By NCAB Committee

February 19, 1982

FDA developing guidelines for oncology endpoints.

May 7, 2004

Report Finds NIH Not At Fault in Case Of P-32 Ingestion

September 26, 1997